Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OBI PharmaROCO:4174 -0.95%36 OCF Yield % is -44.43 as of Aug. 30, 2026. GuruFocus rates ROCO:4174 with a GF Score™ of 36/100. The stock has 8 warning signs investors should review. Among 1,408 Biotechnology companies, OBI Pharma ranks worse than 82.74% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
OBI Pharma OCF Yield % Related Terms
OBI Pharma OCF Yield % Historical Data
* Premium members only.
The historical data trend for OBI Pharma's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4174 vs VRTX, REGN, RVMD: OCF Yield % Comparison
For the Biotechnology subindustry, OBI Pharma's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OBI Pharma OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OBI Pharma's OCF Yield % distribution charts can be found below:
* The bar in red indicates where OBI Pharma's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OBI Pharma (ROCO:4174) has a OCF Yield % of -44.43 as of Aug. 30, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on OBI Pharma and its competitors. According to the industry distribution chart, OBI Pharma ranks #1165 out of 1408 companies in the Biotechnology industry, placing it in the top 82.7%.
Is OBI Pharma's OCF Yield % too high?
OBI Pharma's current OCF Yield % is -44.43. Based on the distribution chart, OBI Pharma ranks #1165 out of 1408 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, OBI Pharma has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does OBI Pharma's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OBI Pharma ranks #1165 out of 1408 companies for OCF Yield %. This places OBI Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on OBI Pharma and its competitors. OBI Pharma's current OCF Yield % is -44.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OBI Pharma stock overvalued right now?
OBI Pharma (ROCO:4174) has a current OCF Yield % of -44.43. The current OCF Yield % is -44.43. OBI Pharma's overall GF Score™ is 36/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For OBI Pharma (ROCO:4174), the current OCF Yield % is -44.43 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OBI Pharma Inc is engaged in the research and development of novel therapeutic agents and biologics for patients with unmet medical needs. The company has three reportable segments: the anti-cancer new drug segment, the botulinum toxin new drug segment, and the CDMO segment. Geographically, it generates the majority of its revenue from Taiwan.
36GF Score
Get the complete analysis for ROCO:4174
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4174 has been successfully added to your 
